These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 16404556)

  • 1. Hepatoblastoma: an oncological review.
    Roebuck DJ; Perilongo G
    Pediatr Radiol; 2006 Mar; 36(3):183-6. PubMed ID: 16404556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: A report from the Children's Cancer Group and the Pediatric Oncology Group.
    Ortega JA; Douglass EC; Feusner JH; Reynolds M; Quinn JJ; Finegold MJ; Haas JE; King DR; Liu-Mares W; Sensel MG; Krailo MD
    J Clin Oncol; 2000 Jul; 18(14):2665-75. PubMed ID: 10894865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiated treatment protocols for high- and standard-risk hepatoblastoma--an interim report of the German Liver Tumor Study HB99].
    Häberle B; Bode U; von Schweinitz D
    Klin Padiatr; 2003; 215(3):159-65. PubMed ID: 12778356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addition of Vincristine and Irinotecan to Standard Therapy in a Patient With Refractory High-risk Hepatoblastoma Achieving Long-term Relapse-free Survival.
    Powers JM; Pacheco MM; Wickiser JE
    J Pediatr Hematol Oncol; 2019 Apr; 41(3):e171-e173. PubMed ID: 29668545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified platinum therapy is an ineffective strategy for improving outcome in pediatric patients with advanced hepatoblastoma.
    Malogolowkin MH; Katzenstein H; Krailo MD; Chen Z; Bowman L; Reynolds M; Finegold M; Greffe B; Rowland J; Newman K; Womer RB; London WB; Castleberry RP
    J Clin Oncol; 2006 Jun; 24(18):2879-84. PubMed ID: 16782927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin versus cisplatin plus doxorubicin for standard-risk hepatoblastoma.
    Perilongo G; Maibach R; Shafford E; Brugieres L; Brock P; Morland B; de Camargo B; Zsiros J; Roebuck D; Zimmermann A; Aronson D; Childs M; Widing E; Laithier V; Plaschkes J; Pritchard J; Scopinaro M; MacKinlay G; Czauderna P
    N Engl J Med; 2009 Oct; 361(17):1662-70. PubMed ID: 19846851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of childhood high-risk hepatoblastoma with dose-intensive multiagent chemotherapy and surgery: final results of the SIOPEL-3HR study.
    Zsíros J; Maibach R; Shafford E; Brugieres L; Brock P; Czauderna P; Roebuck D; Childs M; Zimmermann A; Laithier V; Otte JB; de Camargo B; MacKinlay G; Scopinaro M; Aronson D; Plaschkes J; Perilongo G
    J Clin Oncol; 2010 May; 28(15):2584-90. PubMed ID: 20406943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
    Katzenstein HM; London WB; Douglass EC; Reynolds M; Plaschkes J; Finegold MJ; Bowman LC
    J Clin Oncol; 2002 Aug; 20(16):3438-44. PubMed ID: 12177104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach--results of the first prospective study of the International Society of Pediatric Oncology.
    Pritchard J; Brown J; Shafford E; Perilongo G; Brock P; Dicks-Mireaux C; Keeling J; Phillips A; Vos A; Plaschkes J
    J Clin Oncol; 2000 Nov; 18(22):3819-28. PubMed ID: 11078495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatoblastoma: A success report using a combination therapy with preoperative arterial embolization.
    Ferreira H; São Simão T; Maia I; Maia A; Castro J; Gonçalves B; Pinto A
    Gastroenterol Hepatol; 2018 Apr; 41(4):262-264. PubMed ID: 28473171
    [No Abstract]   [Full Text] [Related]  

  • 11. Analysis of treatment efficiency of carboplatin and etoposide in combination with radical surgery in advanced and recurrent childhood hepatoblastoma: a report of the German Cooperative Pediatric Liver Tumor Study HB 89 and HB 94.
    Fuchs J; Bode U; von Schweinitz D; Weinel P; Erttmann R; Harms D; Mildenberger H
    Klin Padiatr; 1999; 211(4):305-9. PubMed ID: 10472567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redefining the role of doxorubicin for the treatment of children with hepatoblastoma.
    Malogolowkin MH; Katzenstein HM; Krailo M; Chen Z; Quinn JJ; Reynolds M; Ortega JA
    J Clin Oncol; 2008 May; 26(14):2379-83. PubMed ID: 18467729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved long-term survival with preoperative chemotherapy for hepatoblastoma.
    Ehrlich PF; Greenberg ML; Filler RM
    J Pediatr Surg; 1997 Jul; 32(7):999-1002; discussion 1002-3. PubMed ID: 9247221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy in the treatment of hepatoblastoma.
    Staines A; Cullen S; Guiney EJ; Fitzgerald RJ; Breatnach F
    Pediatr Hematol Oncol; 1990; 7(2):205-7. PubMed ID: 1698434
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatoblastoma presenting with focal nodular hyperplasia after treatment of neuroblastoma.
    Gutweiler JR; Yu DC; Kim HB; Kozakewich HP; Marcus KJ; Shamberger RC; Weldon CB
    J Pediatr Surg; 2008 Dec; 43(12):2297-300. PubMed ID: 19040959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
    von Schweinitz D; Byrd DJ; Hecker H; Weinel P; Bode U; Bürger D; Erttmann R; Harms D; Mildenberger H
    Eur J Cancer; 1997 Jul; 33(8):1243-9. PubMed ID: 9301450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol.
    Hiyama E; Hishiki T; Watanabe K; Ida K; Yano M; Oue T; Iehara T; Hoshino K; Koh K; Tanaka Y; Kurihara S; Ueda Y; Onitake Y
    J Pediatr Surg; 2016 Dec; 51(12):2053-2057. PubMed ID: 27712887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A trend of improved survival of childhood hepatoblastoma treated with cisplatin and doxorubicin in Taiwanese children.
    Chiu SN; Ni YH; Lu MY; Lin DT; Lin KH; Lai HS; Chang MH
    Pediatr Surg Int; 2003 Oct; 19(8):593-7. PubMed ID: 14556026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy for unresectable hepatoblastoma in children.
    Ogita S; Tokiwa K; Takahashi T; Imashuku S; Sawada T
    Jpn J Surg; 1987 Jan; 17(1):21-7. PubMed ID: 3033374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatoblastoma--evolution of management and outcome and significance of histology of the resected tumor. A 31-year experience with 40 cases.
    Davies JQ; de la Hall PM; Kaschula RO; Sinclair-Smith CC; Hartley P; Rode H; Millar AJ
    J Pediatr Surg; 2004 Sep; 39(9):1321-7. PubMed ID: 15359384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.